Park Ha Biological Technology (BYAH) Cash & Current Investments (2023 - 2026)

Park Ha Biological Technology has reported Cash & Current Investments for 4 years, with the latest figure at $5.7 million in Q2 2026.

• On a quarterly basis, Cash & Current Investments rose 317.86% year-over-year to $5.7 million in Q2 2026; TTM through Apr 2026 was $5.7 million, a 317.86% increase from a year earlier, with the FY2025 full-year figure at $3.8 million, up 570.07% from the prior year.
• Cash & Current Investments was $5.7 million for Q2 2026 at Park Ha Biological Technology, up from $3.8 million in the prior quarter.
• The five-year high for Cash & Current Investments was $5.7 million in Q2 2026, with the low at $566666.0 in Q4 2024.
• Average Cash & Current Investments over 4 years is $2.5 million, with a median of $1.4 million recorded in 2025.
• The sharpest annual moves came in 2024 and 2025: Cash & Current Investments sank 45.21% in 2024, then surged 570.07% in 2025.
• Over 4 years, Cash & Current Investments stood at $1.0 million in 2023, then tumbled by 45.21% to $566666.0 in 2024, then soared by 570.07% to $3.8 million in 2025, then soared by 49.0% to $5.7 million in 2026.
• The last three Cash & Current Investments figures came in at $5.7 million (Q2 2026), $3.8 million (Q4 2025), and $1.4 million (Q2 2025), per Business Quant data.